Ranbaxy First to Gain Approval to Manufacture and Market Clarithromycin for Oral Suspension, USP
Ranbaxy One of Few Companies to Offer Both Suspension and Tablet Forms
PRINCETON, N.J., Oct. 2 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc.
(RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL),
announced today that RLL has received final approval from the U.S. Food and
Jiangbo Pharmaceuticals Reports Results for the Third Quarter of its Fiscal Year 2009
...ndependent distributors by
an average of 26.0% for clarithromycin
Sustained-released tablets, Itopride
Hydrochloride...m Hongrui in January 2009.
Sales volume for clarithromycin
Sustained-released tablets and Baobaole
chewable t...009 than in
the three months ended March 31, 2008. clarithromycin
tablets, Itopride hydrochloride...
China Pharma Holdings, Inc. Reports Record 2008 Year End Financial Results and Corporate Updates
..., and the sales of other products also
improved dramatically: year-on-year Alginic Sodium Diester increased by 75.5%,
Granisetron increased by 60.47%, clarithromycin
increased by 57.4%.
The financial operational performance for the 12 months ended December 31,
2008 was clearly improved compared to the 12 mon...
Why does aspirin increase the susceptibility of Helicobacter pylori to antimicrobials?
...ivity of virulence factors of H. pylori . In addition, aspirin increased the susceptibility of H. pylori to antimicrlbials including metronidazole, clarithromycin
and amoxicillin. However, the mechanisms remained unknown.
A research team led by Prof. Wang from Peking University First Hospital of China address...
An ideal therapy for peptic ulcer disease
...ation became the main objective of therapy, and several treatment regimens were developed. Currently, triple therapy with omeprazole, amoxicillin, and clarithromycin
remains the best therapeutic option. Despite its efficacy, 10% to 20% of the patients present with treatment failure, demanding alternative therapeuti...
Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008
... from $18.9 million in the prior year's period. This
increase in revenue was mostly due to increased sales of the Company's two
most popular products, clarithromycin
sustained-release tablets and
Itopride Hydrochloride Granules as well as sales of Baobaole chewable
tablets, which grew rapidly from the time the prod...
Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
...t of exchange of 10.5 percent, Kaletra sales increased 20.7 percent internationally. (c) Without the positive impact of exchange of 9.6 percent, clarithromycin
sales decreased 10.0 percent internationally. (d) Without the positive impact of exchange of 9.4 percent, Sevorane sales increased 4.4 perc...
GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
...azole Avoid lovastatin Ketoconazole Erythromycin clarithromycin
Telithromycin HIV protease inhibitors Nefazodone
Itraconazole Ketoconazole Erythromycin clarithromycin
Telithromycin HIV protease inhibitors Nefazodone Large quantities of gr...
Genesis Pharmaceuticals Announces Results for The First Quarter of Fiscal Year 2008
...mpared to 71.8% for the prior year
period, a slight increase of 0.5%. This increase was due to more efficient
manufacturing production by the Company. clarithromycin
tablets accounted for 65.3% of total revenue during the quarter, with a
gross margin approaching 80.0%, and Itopride Hydrochloride g...
Pharma Major Ind-Swift to Enter US, Japan
...ake a foray// into the Japanese drug market.
Ind-Swift Laboratories has completed United State Federal Drug Authority (USFDA) inspection for its clarithromycin
active pharmaceutical ingredient (API) manufacturing unit, its managing director N.R. Munjal said here Thursday.
Clarithromycin is a macrolide a...
Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity
... of the first group, NAB 7061, sensitizes enteric
bacteria to other antibiotics. For example, it reduces the minimum
inhibitory concentration (MIC) of clarithromycin
for ESBL-producing strains
of Escherichia coli by a factor of 250-750. NAB 739, the lead compound of
the second series, acts directly against enteric ...
Watson Launches Generic Biaxin(R) XL
...n. 3 /PRNewswire-FirstCall/ -- Watson
Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical
company, announced today it has launched clarithromycin
Tablets, USP in the 500 mg strength. Watson's Clarithromycin
Extended-Release product is the generic equivalent to Abbott's Biaxin(R)...
FDA approves MyocondaR IND for MAP in Crohn's Disease
...condaR, the Company's Anti-MAP therapy for the treatment
of Crohn's Disease is a combination of three registered
anti-mycobacterial drugs - rifabutin, clarithromycin
clofazimine. These three drugs are widely marketed world-wide for
the treatment of mycobacterial and other infections. MyocondaR
presents these th...
Scientists discover bacteria that can cause bone infections
...ents. Most mycobacterial infections can be treated with antibiotics such as clarithromycin
and rifamycins, but some species are becoming resistant to these antibiotic...terium arosiense can be killed by several antibiotics in the lab, including clarithromycin
and rifamycins. However, resistance to fluoroquinolones and isoniazid was o...
UIC scientists discover how some bacteria survive antibiotics
...n feel the presence of erythromycin and activate production of the resistance genes."
Erythromycin and newer macrolide antibiotics azithromycin and clarithromycin
are often used to treat respiratory tract infections, as well as outbreaks of syphilis, acne and gonorrhea. The drugs can be used by patients allergic...